Why This Matters for Your Career
Partner Therapeutics is hiring 1 role related to this product
NITAZOXANIDE (nitazoxanide) by Partner Therapeutics is 12. Approved for diarrhea caused by giardia lamblia, cryptosporidium parvum, cryptosporidium parvum limitations of use: nitazoxanide tablets have not been shown to be effective for the treatment of diarrhea caused by c. First approved in 2020.
Drug data last refreshed 19h ago
12.1 Mechanism of Action Nitazoxanide is an antiprotozoal [see ]. 12.3 Pharmacokinetics Absorption Single Dosing: Following oral administration of nitazoxanide tablets or oral suspension, the parent drug, nitazoxanide, is not detected in plasma. The pharmacokinetic parameters of the metabolites,…
Worked on NITAZOXANIDE at Partner Therapeutics? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Antiprotozoal
Nitazoxanide for Treatment of Cryptosporidium in Children
Pharmacokinetic Study on G1090N (Nitazoxanide) Capsules in Healthy Volunteers
Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without Constipation
Nitazoxanide Pharmacokinetic Parameters in Renal Impaired Subjects
Nitazoxanide Pharmacokinetic Parameters in Hepatic Impaired Patients
Partner Therapeutics is hiring 1 role related to this product